AAGH
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and the manufacturing and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health was founded in 2013 and is headquartered in Alhambra, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q1 | 0.00 | $187,559 | $44,466 |
| 2025 Q4 | 0.00 | $104,530 | -$272,565 |
| 2025 Q3 | 0.00 | $56,148 | -$53,496 |
| 2024 Q2 | 0.00 | $90,939 | $88,777 |
| 2024 Q1 | 0.00 | $140,126 | -$95,578 |
| 2024 Q4 | -0.00 | $95,651 | -$294,460 |
| 2024 Q3 | 0.00 | $94,032 | $103,918 |
| 2023 Q2 | 0.00 | $91,179 | -$304,277 |